Materiały źródłowe

• #1 Mild Cognitive Impairment: Diagnosis and Subtypes – PubMed

  https://pubmed.ncbi.nlm.nih.gov/34549629/

  Mild cognitive impairment (MCI) is a clinical diagnosis based on subjective cognitive decline, objective cognitive impairment, and relative preservation of activities of daily living. The diagnosis may be established via clinical interview, collateral history from an informant, and psychometric examination. Various consensus groups have proposed criteria for MCI in Alzheimer’s disease (AD), Parkinson’s disease, dementia with Lewy bodies, and vascular cognitive impairment. These diagnostic criteria have subtle but important differences. Criteria for subjective decline vary according to whether memory is impaired or whether impairment in any cognitive domain is sufficient. There are also differences with respect to whether the subjective decline is noted by the patient, a carer, or a clinician. The precise thresholds for classifying objective cognitive impairment also vary between various diagnostic criteria. There are also differences in the description of functional abilities. Once established, the diagnosis of MCI may be refined to 1 of 4 subtypes based on the pattern of cognitive impairment. The 4 subtypes are defined according to whether or not memory is impaired and whether 1 or more cognitive domains are impaired. Once a diagnosis of MCI has been made, the patient and the family should be counseled about social and legal implications as well as strategies for reducing the risk of progression to dementia. The main utilities of MCI as a nosology are to understand the natural history of neurodegenerative disorders such as AD, to identify those at increased risk of progressing to develop dementia, and to identifying individuals for putative treatments.

• #2 Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4169219/

  Mild cognitive impairment (MCI) is widely regarded as the intermediate stage of cognitive impairment between the changes seen in normal cognitive aging and those associated with dementia. Elderly patients with MCI constitute a high-risk population for developing dementia, in particular Alzheimers disease (AD). […] Although the core clinical criteria for MCI have remained largely unchanged, the operational definition of MCI has undergone several revisions over the course of the last decade and remains an evolving diagnosis. The aim of this review is to first provide a brief overview of the evolution of the concept of MCI and longitudinal course of the disorder. We will then discuss various issues to consider when making a clinical diagnosis of MCI and review current and emerging treatments for MCI.

• #3 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  No one test can diagnose mild cognitive impairment, also known as MCI. A diagnosis is made based on the information you provide, your medical evaluation and results of tests. […] Many healthcare professionals diagnose MCI based on criteria developed by a panel of international experts: […] Changes in memory or another mental ability. People with MCI may have symptoms related to memory, planning, following instructions or making decisions. A healthcare professional may confirm these issues with a family member or a close friend. […] Mental ability that declines over time. This is revealed with a careful medical history. The change is confirmed by a family member or a close friend. […] Daily activities aren’t affected. Symptoms may cause worry, but people with MCI are still able to live their lives as usual.

• #4 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  No one test can diagnose mild cognitive impairment, also known as MCI. A diagnosis is made based on the information you provide, your medical evaluation and results of tests. […] Many healthcare professionals diagnose MCI based on criteria developed by a panel of international experts: […] Changes in memory or another mental ability. People with MCI may have symptoms related to memory, planning, following instructions or making decisions. A healthcare professional may confirm these issues with a family member or a close friend. […] Mental ability that declines over time. This is revealed with a careful medical history. The change is confirmed by a family member or a close friend. […] Daily activities aren’t affected. Symptoms may cause worry, but people with MCI are still able to live their lives as usual.

• #5 Evaluating MCI (Mild Cognitive Impairment) – Harvard Health

  https://www.health.harvard.edu/mind-and-mood/evaluating-mci-mild-cognitive-impairment

  Losing things, forgetting appointments, trouble coming up with words. These may be signs of Mild Cognitive Impairment, or MCI. MCI is a condition that some older adults experience in which they have more memory or thinking problems that other adults their age. Symptoms suggestive of MCI are less pronounced than symptoms of Alzheimer’s disease or other type of dementia but should still be evaluated by a doctor. […] The primary objective of an evaluation should be to distinguish MCI from normal aging or dementia and to look for underlying causes that are potentially reversible. Establishing the cause and scope of the impairment is helpful in setting a baseline for future cognitive evaluations. […] The journey toward a diagnosis of MCI is most often initiated by a person’s subjective complaint about memory and thinking problems or by concerns expressed by those closest to the individual.

• #6 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  No one test can diagnose mild cognitive impairment, also known as MCI. A diagnosis is made based on the information you provide, your medical evaluation and results of tests. […] Many healthcare professionals diagnose MCI based on criteria developed by a panel of international experts: […] Changes in memory or another mental ability. People with MCI may have symptoms related to memory, planning, following instructions or making decisions. A healthcare professional may confirm these issues with a family member or a close friend. […] Mental ability that declines over time. This is revealed with a careful medical history. The change is confirmed by a family member or a close friend. […] Daily activities aren’t affected. Symptoms may cause worry, but people with MCI are still able to live their lives as usual.

• #7 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  No one test can diagnose mild cognitive impairment, also known as MCI. A diagnosis is made based on the information you provide, your medical evaluation and results of tests. […] Many healthcare professionals diagnose MCI based on criteria developed by a panel of international experts: […] Changes in memory or another mental ability. People with MCI may have symptoms related to memory, planning, following instructions or making decisions. A healthcare professional may confirm these issues with a family member or a close friend. […] Mental ability that declines over time. This is revealed with a careful medical history. The change is confirmed by a family member or a close friend. […] Daily activities aren’t affected. Symptoms may cause worry, but people with MCI are still able to live their lives as usual.

• #8 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  No one test can diagnose mild cognitive impairment, also known as MCI. A diagnosis is made based on the information you provide, your medical evaluation and results of tests. […] Many healthcare professionals diagnose MCI based on criteria developed by a panel of international experts: […] Changes in memory or another mental ability. People with MCI may have symptoms related to memory, planning, following instructions or making decisions. A healthcare professional may confirm these issues with a family member or a close friend. […] Mental ability that declines over time. This is revealed with a careful medical history. The change is confirmed by a family member or a close friend. […] Daily activities aren’t affected. Symptoms may cause worry, but people with MCI are still able to live their lives as usual.

• #9 Mild cognitive impairment – Wikipedia

  https://en.wikipedia.org/wiki/Mild_cognitive_impairment

  The diagnosis of MCI requires clinical judgement, possibly including clinical observation, neuroimaging, blood tests and neuropsychological testing. […] MCI may be diagnosed differently by different clinicians using different definitions or criteria, but generally including: Evidence of modest cognitive decline from a previous level of performance in one or more cognitive domains, based on either: concern about cognitive decline from the individual, a knowledgeable informant, or a clinician, or modest impairment in cognitive performance documented by standardized neuropsychological testing. […] The cognitive deficits do not interfere with capacity for independence in everyday activities. However, greater effort, compensatory strategies, or accommodation may be required for complex tasks.

• #10 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #11 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #12 Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4169219/

  The first clinical criteria for MCI, developed by Petersen et al. (referred to as original Mayo Clinic criteria), focused primarily on episodic memory impairment (i.e., the ability to learn and retain new information) problems. […] According to the revised Mayo Clinic criteria, patients with MCI were classified as amnestic MCI (a-MCI) if patients exhibited performance deficits on neuropsychological tests of episodic memory, or non-amnestic MCI (na-MCI) if patients exhibited performance deficits on neuropsychological tests of non-memory domains of cognition. […] In 2011 the National Institute on Aging-Alzheimers Association (NIA-AA) workgroup proposed criteria specifically for MCI due to AD for use in clinical and research settings. […] The DSM-5 takes a two step approach that first involves differentiating between normal neurocognitive function, mild NCD, and major NCD (or dementia), and then determining the underlying etiology.

• #13 Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4169219/

  The first clinical criteria for MCI, developed by Petersen et al. (referred to as original Mayo Clinic criteria), focused primarily on episodic memory impairment (i.e., the ability to learn and retain new information) problems. […] According to the revised Mayo Clinic criteria, patients with MCI were classified as amnestic MCI (a-MCI) if patients exhibited performance deficits on neuropsychological tests of episodic memory, or non-amnestic MCI (na-MCI) if patients exhibited performance deficits on neuropsychological tests of non-memory domains of cognition. […] In 2011 the National Institute on Aging-Alzheimers Association (NIA-AA) workgroup proposed criteria specifically for MCI due to AD for use in clinical and research settings. […] The DSM-5 takes a two step approach that first involves differentiating between normal neurocognitive function, mild NCD, and major NCD (or dementia), and then determining the underlying etiology.

• #14 Mild Cognitive Impairment – Penn Memory Center

  https://pennmemorycenter.org/education-and-support-resources/understanding-my-diagnosis/ed-mild-cognitive-impairment/

  Mild cognitive impairment (MCI) is a condition in which people have more memory or other thinking problems than normal for their age, but their symptoms do not cause disability. […] Although MCI is not dementia, people with MCI are at greater risk for developing dementia. […] On average, about 50% of those who have MCI go on to develop dementia, while the other 50% of people do not. […] Some may even go back to normal cognition. […] There are two types of MCI: amnestic and non-amnestic MCI. […] Amnestic MCI is characterized predominately by memory impairment. […] Non-Amnestic MCI is characterized predominately by impairment in cognitive domains other than memory, such as language, attention, executive functioning, and visuospatial abilities. […] Currently, no drugs or other treatments are approved for mild cognitive impairment (MCI) by the Food and Drug Administration (FDA).

• #15 Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4169219/

  The first clinical criteria for MCI, developed by Petersen et al. (referred to as original Mayo Clinic criteria), focused primarily on episodic memory impairment (i.e., the ability to learn and retain new information) problems. […] According to the revised Mayo Clinic criteria, patients with MCI were classified as amnestic MCI (a-MCI) if patients exhibited performance deficits on neuropsychological tests of episodic memory, or non-amnestic MCI (na-MCI) if patients exhibited performance deficits on neuropsychological tests of non-memory domains of cognition. […] In 2011 the National Institute on Aging-Alzheimers Association (NIA-AA) workgroup proposed criteria specifically for MCI due to AD for use in clinical and research settings. […] The DSM-5 takes a two step approach that first involves differentiating between normal neurocognitive function, mild NCD, and major NCD (or dementia), and then determining the underlying etiology.

• #16 Mild Cognitive Impairment – Penn Memory Center

  https://pennmemorycenter.org/education-and-support-resources/understanding-my-diagnosis/ed-mild-cognitive-impairment/

  Mild cognitive impairment (MCI) is a condition in which people have more memory or other thinking problems than normal for their age, but their symptoms do not cause disability. […] Although MCI is not dementia, people with MCI are at greater risk for developing dementia. […] On average, about 50% of those who have MCI go on to develop dementia, while the other 50% of people do not. […] Some may even go back to normal cognition. […] There are two types of MCI: amnestic and non-amnestic MCI. […] Amnestic MCI is characterized predominately by memory impairment. […] Non-Amnestic MCI is characterized predominately by impairment in cognitive domains other than memory, such as language, attention, executive functioning, and visuospatial abilities. […] Currently, no drugs or other treatments are approved for mild cognitive impairment (MCI) by the Food and Drug Administration (FDA).

• #17 Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4169219/

  The first clinical criteria for MCI, developed by Petersen et al. (referred to as original Mayo Clinic criteria), focused primarily on episodic memory impairment (i.e., the ability to learn and retain new information) problems. […] According to the revised Mayo Clinic criteria, patients with MCI were classified as amnestic MCI (a-MCI) if patients exhibited performance deficits on neuropsychological tests of episodic memory, or non-amnestic MCI (na-MCI) if patients exhibited performance deficits on neuropsychological tests of non-memory domains of cognition. […] In 2011 the National Institute on Aging-Alzheimers Association (NIA-AA) workgroup proposed criteria specifically for MCI due to AD for use in clinical and research settings. […] The DSM-5 takes a two step approach that first involves differentiating between normal neurocognitive function, mild NCD, and major NCD (or dementia), and then determining the underlying etiology.

• #18 Evaluating MCI (Mild Cognitive Impairment) – Harvard Health

  https://www.health.harvard.edu/mind-and-mood/evaluating-mci-mild-cognitive-impairment

  Losing things, forgetting appointments, trouble coming up with words. These may be signs of Mild Cognitive Impairment, or MCI. MCI is a condition that some older adults experience in which they have more memory or thinking problems that other adults their age. Symptoms suggestive of MCI are less pronounced than symptoms of Alzheimer’s disease or other type of dementia but should still be evaluated by a doctor. […] The primary objective of an evaluation should be to distinguish MCI from normal aging or dementia and to look for underlying causes that are potentially reversible. Establishing the cause and scope of the impairment is helpful in setting a baseline for future cognitive evaluations. […] The journey toward a diagnosis of MCI is most often initiated by a person’s subjective complaint about memory and thinking problems or by concerns expressed by those closest to the individual.

• #19 Diagnosing and getting treatment for MCI | Alzheimer’s Society

  https://www.alzheimers.org.uk/about-dementia/types-dementia/mild-cognitive-impairment-treatments

  Diagnosing MCI can help people get access to any help or support they may need. Thinking problems can be assessed at the GP or a memory service. […] The GP will ask about a persons symptoms. This includes when they started and how they are affecting their daily life. They will review the persons physical health and any medicines they are taking. They will also briefly test their thinking skills. If the GP thinks there may be a problem with memory or thinking they will normally refer the person to their local memory service for a specialist assessment. […] A diagnosis of MCI is usually given when a persons memory or thinking is worse than would be expected for their age but its not affecting their ability to do everyday activities. […] A diagnosis of MCI can be helpful for anyone struggling to convince people around them that they have a problem and need help or support.

• #20 Mild Cognitive Impairment (MCI) | Symptoms & Treatments | alz.org

  https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment

  The guidelines recommend finding a biomarker (a measurable biological factor, such as levels of a protein, that indicates the presence or absence of a disease) for people with MCI to learn whether they have brain changes that put them at high risk of developing Alzheimers and other dementias. […] If it can be shown that changes in the brain, cerebrospinal fluid and/or blood are caused by physiologic processes associated with Alzheimers, the revised guidelines recommend a diagnosis of MCI due to Alzheimers disease. […] A medical workup for MCI includes the following core elements: Thorough medical history, where the physician documents current symptoms, previous illnesses and medical conditions, and any family history of significant memory problems or dementia. […] The causes of MCI are not yet completely understood.

• #21 Mild Cognitive Impairment | Memory and Aging Center

  https://memory.ucsf.edu/dementia/mild-cognitive-impairment

  In contrast to Alzheimers disease (AD) where other cognitive skills and the ability to live independently are affected, mild cognitive impairment (MCI) is defined by deficits in memory that do not significantly impact daily functioning. […] The diagnosis of MCI relies on the fact that the individual is able to perform all their usual activities successfully, without more assistance from others than they previously needed. […] The medical evaluation should include a thorough exploration of the memory complaints, including what type of information is being forgotten and when, the duration of the problem, and whether other cognitive complaints are occurring (problems with organization, planning, visuospatial abilities, etc.). […] Additional assessment could include neuropsychological testing to document objectively any memory deficit and to assess its severity.

• #22 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  No one test can diagnose mild cognitive impairment, also known as MCI. A diagnosis is made based on the information you provide, your medical evaluation and results of tests. […] Many healthcare professionals diagnose MCI based on criteria developed by a panel of international experts: […] Changes in memory or another mental ability. People with MCI may have symptoms related to memory, planning, following instructions or making decisions. A healthcare professional may confirm these issues with a family member or a close friend. […] Mental ability that declines over time. This is revealed with a careful medical history. The change is confirmed by a family member or a close friend. […] Daily activities aren’t affected. Symptoms may cause worry, but people with MCI are still able to live their lives as usual.

• #23 Mild Cognitive Impairment | University of Michigan Health

  https://www.uofmhealth.org/conditions-treatments/brain-neurological-conditions/mild-cognitive-impairment

  Mild Cognitive Impairment (MCI) is a disorder of memory or other related cognitive process. A person with MCI experiences greater memory and thinking difficulties than expected with aging. However, the problems do not impair their ability to complete daily activities (as they do in other diseases causing dementia). It is important to recognize MCI because it puts a person at a greater risk of developing dementia in the future. […] MCI is a clinical diagnosis representing a doctors best professional judgment about the reason for a persons symptoms. If a physician has difficulty confirming a diagnosis of MCI or the cause of MCI, brain imaging and cerebrospinal fluid tests may be performed to determine if the individual has MCI due to Alzheimers disease. […] A medical exam for MCI includes: Thorough medical history, Assessment of independent function and daily activities, Input from a family member on function, Assessment of mental status, In-office neurological exam, Evaluation of mood, Laboratory tests.

• #24 Mild Cognitive Impairment – Connecticut Behavioral Health Associates, P.C.

  https://www.ctbehavioralhealthassociates.com/medical-conditions/mild-cognitive-impairment/

  Mild cognitive impairment is a clinical diagnosis representing a doctors best professional judgment about the reason for a persons symptoms. There are currently no tests or procedures to demonstrate conclusively that a person has MCI. Its also not yet possible to determine the underlying cause of MCI in a specific person. […] A medical workup for MCI includes the following core elements: Thorough medical history, where the physician documents current symptoms, previous illnesses and medical conditions, and any family history of significant memory problems or dementia. Assessment of independent function and daily activities, which focuses on any changes from a persons usual level of function. Input from a family member or trusted friend to provide additional perspective on how function may have changed. Assessment of mental status using brief tests designed to evaluate memory, planning, judgment, ability to understand visual information and other key thinking skills. In-office neurological examination to assess the function of nerves and reflexes, movement, coordination, balance and senses. Evaluation of mood to detect depression; symptoms may include problems with memory or feeling foggy. Depression is widespread and may be especially common in older adults. Laboratory tests including blood tests and imaging of the brains structure. […] If the workup doesnt create a clear clinical picture, the doctor may recommend neuropsychological testing, which involves a series of written or computerized tests to evaluate specific thinking skills.

• #25 Mild Cognitive Impairment – Connecticut Behavioral Health Associates, P.C.

  https://www.ctbehavioralhealthassociates.com/medical-conditions/mild-cognitive-impairment/

  Mild cognitive impairment is a clinical diagnosis representing a doctors best professional judgment about the reason for a persons symptoms. There are currently no tests or procedures to demonstrate conclusively that a person has MCI. Its also not yet possible to determine the underlying cause of MCI in a specific person. […] A medical workup for MCI includes the following core elements: Thorough medical history, where the physician documents current symptoms, previous illnesses and medical conditions, and any family history of significant memory problems or dementia. Assessment of independent function and daily activities, which focuses on any changes from a persons usual level of function. Input from a family member or trusted friend to provide additional perspective on how function may have changed. Assessment of mental status using brief tests designed to evaluate memory, planning, judgment, ability to understand visual information and other key thinking skills. In-office neurological examination to assess the function of nerves and reflexes, movement, coordination, balance and senses. Evaluation of mood to detect depression; symptoms may include problems with memory or feeling foggy. Depression is widespread and may be especially common in older adults. Laboratory tests including blood tests and imaging of the brains structure. […] If the workup doesnt create a clear clinical picture, the doctor may recommend neuropsychological testing, which involves a series of written or computerized tests to evaluate specific thinking skills.

• #26 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #27 What Is Mild Cognitive Impairment, and How is it Diagnosed? – The New York Times

  https://www.nytimes.com/2024/02/06/well/mind/mild-cognitive-impairment-diagnosis.html

  Most people are first screened for M.C.I. and dementia in their primary care doctor’s office. Medicare requires physicians to assess cognitive health at the annual wellness visit, which people are eligible for starting at 65, though those screens can be as basic as asking the patient whether they’ve noticed any issues with their memory. Typically, a physician only initiates a longer dementia test if the patient or a family member has expressed concern, Dr. Amjad said. […] Two commonly used cognitive tests to diagnose M.C.I. and dementia are the Mini-Mental State Exam and the Montreal Cognitive Assessment. Both take about 10 minutes and involve questions evaluating memory, attention, verbal ability and general awareness. For example, the doctor might ask the patient to remember a few words and recount them several minutes later, name as many animals as they can or count backward by groups of seven.

• #28 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #29 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #30 What is Mild Cognitive Impairment? • Memory and Aging

  https://mindcrowd.org/what-is-mild-cognitive-impairment/

  Mild cognitive impairment (MCI) is characterized by changes in cognitive performance that are uncommon or atypical for someone’s age and education level. […] MCI is often thought of as a stage between normal aging and dementia. Since it’s not dementia, the implication is that mild cognitive impairment is typically not significant enough to impact your daily life. […] Mild cognitive impairment is primarily identified in people who already have concerns about their cognition but, when tested, they don’t quite rise to the clinical definition of dementia. Their memory or thinking abilities have declined over time but this does not impact their day-to-day activities. […] When doctors assess a person’s mental performance, an MCI patient’s score may show a mild level of impairment for their age and education level. Medical professionals use tests such as the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA) to do these evaluations.

• #31 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #32 What is Mild Cognitive Impairment? • Memory and Aging

  https://mindcrowd.org/what-is-mild-cognitive-impairment/

  Mild cognitive impairment (MCI) is characterized by changes in cognitive performance that are uncommon or atypical for someone’s age and education level. […] MCI is often thought of as a stage between normal aging and dementia. Since it’s not dementia, the implication is that mild cognitive impairment is typically not significant enough to impact your daily life. […] Mild cognitive impairment is primarily identified in people who already have concerns about their cognition but, when tested, they don’t quite rise to the clinical definition of dementia. Their memory or thinking abilities have declined over time but this does not impact their day-to-day activities. […] When doctors assess a person’s mental performance, an MCI patient’s score may show a mild level of impairment for their age and education level. Medical professionals use tests such as the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA) to do these evaluations.

• #32 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #33 Evaluating MCI (Mild Cognitive Impairment) – Harvard Health

  https://www.health.harvard.edu/mind-and-mood/evaluating-mci-mild-cognitive-impairment

  Your regular doctor is a good place to start the process because he or she knows you and your medical history. However, you may need to pursue evaluation a doctor who specializes on cognitive function, such as a behavioral neurologist or a geriatric psychiatrist. […] Before evaluating your cognitive health, your doctor will first want to understand if your memory problems are a symptom of an underlying health problem. […] The doctor will start this evaluation with a detailed history of your cognitive changes over time. […] You may be referred to a psychologist with specialized training in brain disorders for comprehensive neuropsychological tests. […] A brain scan using either computed tomography (CT) or magnetic resonance imaging (MRI) may be done to examine the anatomic structure of the brain. These scans are used to rule out such problems as tumor, infection, bleeding, stroke, and hydrocephalus (excess fluid in the area around the brain).

• #34 What Is Mild Cognitive Impairment (MCI)? Symptoms, Causes, and Treatment

  https://www.everydayhealth.com/alzheimers-disease/mild-cognitive-impairment/guide/

  Mild cognitive impairment (MCI) is an early stage of memory loss or other loss of cognitive (thinking) function for example, losing memory or language skills beyond what would be expected at a persons age or level of distraction or as a result of poor sleep or anxiety. […] A diagnosis of MCI is based on your symptoms and may be guided by a number of different mental assessments, as well as a neurological examination and screening for other conditions like depression. If youre diagnosed with MCI, you may also undergo certain tests that can show whether your MCI is related to Alzheimers disease. […] Many doctors base a diagnosis of MCI on the following criteria, which have been developed by a panel of experts on the condition, according to Mayo Clinic: Problems with memory or another cognitive function, Decline in mental function over time, Daily activities not affected by cognitive issues, Cognitive testing showing mild impairment, No diagnosis of Alzheimers or another type of dementia.

• #35 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #36 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #37 Mild cognitive impairment and dementia: detection and diagnosis | Medicine Today

  https://medicinetoday.com.au/mt/2024/may/feature-article/mild-cognitive-impairment-and-dementia-detection-and-diagnosis

  Dementia affects one in 12 people aged over 65 years. GPs and practice nurses have an important role in detection and assessment, and GPs in the diagnosis of dementia. […] Over 400,000 people in Australia had dementia in 2023, and an estimated 50% of these do not have a formal diagnosis. […] Any member of the primary care team may identify issues and raise concerns that prompt the need to investigate further whether a person has mild cognitive impairment or dementia. An annual health assessment for people aged older than 75 years is a good opportunity to identify issues and concerns that could be related to mild cognitive impairment or dementia. […] A comprehensive assessment can take place over several visits and include both a personal and collaborative history, physical examination and investigations, including blood tests and CT scans.

• #38 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone. […] Blood tests also can check for proteins in the brain that are related to Alzheimer’s disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer’s disease. This test may confirm Alzheimer’s as a cause of cognitive impairment. […] An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer’s disease. […] Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions. […] Longer forms of the tests look at how a person’s mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.

• #39 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone. […] Blood tests also can check for proteins in the brain that are related to Alzheimer’s disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer’s disease. This test may confirm Alzheimer’s as a cause of cognitive impairment. […] An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer’s disease. […] Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions. […] Longer forms of the tests look at how a person’s mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.

• #40 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone. […] Blood tests also can check for proteins in the brain that are related to Alzheimer’s disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer’s disease. This test may confirm Alzheimer’s as a cause of cognitive impairment. […] An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer’s disease. […] Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions. […] Longer forms of the tests look at how a person’s mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.

• #41 Mild Cognitive Impairment (MCI): What You Need To Know

  https://www.healthline.com/health/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is a slight decline in memory or the ability to think clearly. […] Doctors dont consider MCI a form of dementia because its not severe enough to interfere with your daily routine or with your ability to function independently. […] According to the Alzheimers Association, a medical workup for MCI should include at least seven core areas. […] Your doctor shouldnt diagnose any kind of cognitive impairment until they perform all of the following: an assessment of your medical history, including your family history of dementia and any illnesses or medications that could be causing cognitive symptoms, an assessment of your ability to function independently, an assessment of input from those familiar with you to help catch symptoms you might miss, a series of simple mental status tests, a neurological exam in their office, a careful evaluation of your mood and behavior because mental illnesses like schizophrenia, bipolar disorder, and major depression can cause symptoms that mimic dementia, blood tests to help your doctor rule out infections, brain imaging tests to determine whether or not any other disorders may be causing the MCI or dementia.

• #42 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone. […] Blood tests also can check for proteins in the brain that are related to Alzheimer’s disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer’s disease. This test may confirm Alzheimer’s as a cause of cognitive impairment. […] An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer’s disease. […] Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions. […] Longer forms of the tests look at how a person’s mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.

• #43 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone. […] Blood tests also can check for proteins in the brain that are related to Alzheimer’s disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer’s disease. This test may confirm Alzheimer’s as a cause of cognitive impairment. […] An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer’s disease. […] Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions. […] Longer forms of the tests look at how a person’s mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.

• #44 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone. […] Blood tests also can check for proteins in the brain that are related to Alzheimer’s disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer’s disease. This test may confirm Alzheimer’s as a cause of cognitive impairment. […] An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer’s disease. […] Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions. […] Longer forms of the tests look at how a person’s mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.

• #45 Evaluating MCI (Mild Cognitive Impairment) – Harvard Health

  https://www.health.harvard.edu/mind-and-mood/evaluating-mci-mild-cognitive-impairment

  Your regular doctor is a good place to start the process because he or she knows you and your medical history. However, you may need to pursue evaluation a doctor who specializes on cognitive function, such as a behavioral neurologist or a geriatric psychiatrist. […] Before evaluating your cognitive health, your doctor will first want to understand if your memory problems are a symptom of an underlying health problem. […] The doctor will start this evaluation with a detailed history of your cognitive changes over time. […] You may be referred to a psychologist with specialized training in brain disorders for comprehensive neuropsychological tests. […] A brain scan using either computed tomography (CT) or magnetic resonance imaging (MRI) may be done to examine the anatomic structure of the brain. These scans are used to rule out such problems as tumor, infection, bleeding, stroke, and hydrocephalus (excess fluid in the area around the brain).

• #46 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone. […] Blood tests also can check for proteins in the brain that are related to Alzheimer’s disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer’s disease. This test may confirm Alzheimer’s as a cause of cognitive impairment. […] An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer’s disease. […] Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions. […] Longer forms of the tests look at how a person’s mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.

• #47 Mild Cognitive Impairment (MCI) | Symptoms & Treatments | alz.org

  https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is an early stage of memory loss or other cognitive ability loss (such as language or visual/spatial perception) in individuals who maintain the ability to independently perform most activities of daily living. […] Mild cognitive impairment causes cognitive changes that are serious enough to be noticed by the person affected and by family members and friends but do not affect the individuals ability to carry out everyday activities. […] Individuals living with MCI who have an abnormal brain positron emission tomography (PET) scan or spinal fluid test for amyloid beta protein, which is the protein in amyloid plaques (one of the two hallmarks of Alzheimer’s), are considered to have a diagnosis of MCI due to Alzheimers disease. […] The Alzheimer’s Association partnered with the National Institute on Aging (NIA) to convene expert workgroups to update the diagnostic guidelines for MCI due to Alzheimer’s disease, suggesting that, in some cases, MCI is an early stage of Alzheimers or another dementia.

• #48 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Mental status testing shows mild changes for age and education level. These include brief tests such as the Short Test of Mental Status, the Montreal Cognitive Assessment (MoCA) or the Mini-Mental State Examination (MMSE). More detailed testing may show to what degree memory has changed. The tests also may reveal the types of memory most affected and whether other mental skills are affected. […] The diagnosis isn’t dementia. Symptoms aren’t serious enough to be diagnosed as Alzheimer’s disease dementia or another type of dementia. […] As part of a physical exam, a healthcare professional may test how well your brain and nervous system works. These tests can help look for conditions that affect memory and other mental abilities, such as Parkinson’s disease, strokes and tumors. […] If MCI is thought to be due to mild Alzheimer’s disease, tests can check for biomarkers. Biomarkers of Alzheimer’s disease include the buildup of proteins in the brain. These proteins can be found in samples of blood or the fluid that surrounds the brain and spinal cord. Biomarkers also can be found in scans of the brain. If biomarkers are present, MCI symptoms may be a sign of mild Alzheimer’s disease.

• #49 Mild Cognitive Impairment (MCI) | Symptoms & Treatments | alz.org

  https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is an early stage of memory loss or other cognitive ability loss (such as language or visual/spatial perception) in individuals who maintain the ability to independently perform most activities of daily living. […] Mild cognitive impairment causes cognitive changes that are serious enough to be noticed by the person affected and by family members and friends but do not affect the individuals ability to carry out everyday activities. […] Individuals living with MCI who have an abnormal brain positron emission tomography (PET) scan or spinal fluid test for amyloid beta protein, which is the protein in amyloid plaques (one of the two hallmarks of Alzheimer’s), are considered to have a diagnosis of MCI due to Alzheimers disease. […] The Alzheimer’s Association partnered with the National Institute on Aging (NIA) to convene expert workgroups to update the diagnostic guidelines for MCI due to Alzheimer’s disease, suggesting that, in some cases, MCI is an early stage of Alzheimers or another dementia.

• #50 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Blood tests can help rule out some physical causes of memory loss. This can include too little vitamin B-12 or thyroid hormone. […] Blood tests also can check for proteins in the brain that are related to Alzheimer’s disease. A sample of the fluid that surrounds the brain and spinal cord may be removed and checked for proteins related to Alzheimer’s disease. This test may confirm Alzheimer’s as a cause of cognitive impairment. […] An MRI or CT scan can check for a brain tumor, stroke or bleeding. Positron emission tomography (PET) can look for protein buildup related to Alzheimer’s disease. […] Short forms of mental status testing can be done in about 10 minutes. The test will ask to name the date and follow written instructions. […] Longer forms of the tests look at how a person’s mental abilities compare with others of a similar age and education. These tests also may find patterns of change that offer clues about the cause of symptoms.

• #51 Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment

  https://www.mdpi.com/1422-0067/20/17/4149

  Using the genetic, proteomic and imaging markers could be essential for disease risk prediction. […] Several research approaches have been undertaken to diagnose MCI using neuropsychiatry, imaging or different proteomic and genetic markers. MCI diagnostic research falls into two categories: (1) cross-sectional research involving screening for markers that can distinguish MCI from normal controls and (2) longitudinal studies that screen MCI patients for prediction of conversion to dementia. […] Several biomarkers have been described for the diagnosis of MCI that could predict the possible development of dementia. […] The A/T/N system was organized through measurement of biomarkers in plasma and CSF, as well as through imaging analyses. This A/T/N system could be useful for categorizing the multi-domain biomarkers, and predicting possible AD progression.

• #52 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren’t recommended for routine treatment of MCI. They haven’t been found to help prevent dementia, and they can cause side effects. […] Symptoms of MCI can be caused by certain medicines that have side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. […] Other common conditions besides MCI can make you feel forgetful or less mentally sharp than usual. Treating these conditions can help improve your memory and overall mental ability. Conditions that can affect memory include: […] High blood pressure. People with MCI tend to be more likely to have changes to the blood vessels inside their brains. High blood pressure can worsen these problems and may cause memory loss.

• #53 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren’t recommended for routine treatment of MCI. They haven’t been found to help prevent dementia, and they can cause side effects. […] Symptoms of MCI can be caused by certain medicines that have side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. […] Other common conditions besides MCI can make you feel forgetful or less mentally sharp than usual. Treating these conditions can help improve your memory and overall mental ability. Conditions that can affect memory include: […] High blood pressure. People with MCI tend to be more likely to have changes to the blood vessels inside their brains. High blood pressure can worsen these problems and may cause memory loss.

• #54 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  If memory loss is the main symptom of MCI, sometimes cholinesterase inhibitors are prescribed. But these medicines aren’t recommended for routine treatment of MCI. They haven’t been found to help prevent dementia, and they can cause side effects. […] Symptoms of MCI can be caused by certain medicines that have side effects that affect thinking. These side effects are thought to go away once the medicine is stopped. […] Other common conditions besides MCI can make you feel forgetful or less mentally sharp than usual. Treating these conditions can help improve your memory and overall mental ability. Conditions that can affect memory include: […] High blood pressure. People with MCI tend to be more likely to have changes to the blood vessels inside their brains. High blood pressure can worsen these problems and may cause memory loss.

• #55 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Depression. Depression can make someone forgetful and mentally „foggy.” Depression is common in people with MCI. Treating depression may help improve memory, while making it easier to cope with the changes in your life. […] Sleep apnea. In this condition, breathing stops and starts several times during sleep, interfering with getting a good night’s rest. Sleep apnea can make you feel very tired during the day, forgetful and not able to focus. Treatment can improve these symptoms and make you more alert during the day.

• #56 Mild cognitive impairment – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/diagnosis-treatment/drc-20354583

  Depression. Depression can make someone forgetful and mentally „foggy.” Depression is common in people with MCI. Treating depression may help improve memory, while making it easier to cope with the changes in your life. […] Sleep apnea. In this condition, breathing stops and starts several times during sleep, interfering with getting a good night’s rest. Sleep apnea can make you feel very tired during the day, forgetful and not able to focus. Treatment can improve these symptoms and make you more alert during the day.

• #57 What is Mild Cognitive Impairment? • Memory and Aging

  https://mindcrowd.org/what-is-mild-cognitive-impairment/

  The results for a person with MCI are typically not significant enough to be labeled dementia. It is important to note that a diagnosis of MCI typically requires significant clinical judgment by your doctor and this could include multiple tests of your memory and cognition, images of your brain, and blood tests. […] Both MCI and dementia are characterized by objective evidence of cognitive impairments. The main difference between mild cognitive impairment and dementia is that in the latter there is evident interference with daily life functioning. […] A certain percentage of people with MCI go on to eventually have Alzheimer’s disease, vascular dementia, or some other dementia type. […] Not all individuals with mild cognitive impairment progress to dementia. Some people recover in full while others never progress but rather maintain their memory and thinking skills at this new, lower, level. […] Thus, MCI is NOT necessarily a precursor to Alzheimer’s disease or any other dementia. It is a diagnosis that should be taken seriously and managed with the guidance of your physician.

• #58 Mild cognitive impairment (MCI) versus dementia

  https://www.medicalnewstoday.com/articles/mci-versus-dementia

  Mild cognitive impairment (MCI) is a condition that affects a persons thinking and memory skills, but not enough to significantly affect day-to-day life. […] MCI can be an early stage of dementia, but not everyone with MCI will go on to develop dementia. Many people with MCI remain stable or get better. […] Doctors make a diagnosis of MCI using their best professional judgment. They will take a thorough medical history to document symptoms, other medical conditions, and any family history of dementia. […] If the person experiences substantial interference with daily life and the condition affects one or more of their cognitive abilities, a doctor may diagnose dementia rather than MCI. […] Because MCI can be an early indication of more serious problems, people with this diagnosis should see their doctor every 612 months after diagnosis for re-evaluation. […] There is currently no cure for either condition, but people with MCI may be able to take steps to lower their risk of dementia.

• #59 Mild cognitive impairment (MCI) versus dementia

  https://www.medicalnewstoday.com/articles/mci-versus-dementia

  Mild cognitive impairment (MCI) is a condition that affects a persons thinking and memory skills, but not enough to significantly affect day-to-day life. […] MCI can be an early stage of dementia, but not everyone with MCI will go on to develop dementia. Many people with MCI remain stable or get better. […] Doctors make a diagnosis of MCI using their best professional judgment. They will take a thorough medical history to document symptoms, other medical conditions, and any family history of dementia. […] If the person experiences substantial interference with daily life and the condition affects one or more of their cognitive abilities, a doctor may diagnose dementia rather than MCI. […] Because MCI can be an early indication of more serious problems, people with this diagnosis should see their doctor every 612 months after diagnosis for re-evaluation. […] There is currently no cure for either condition, but people with MCI may be able to take steps to lower their risk of dementia.

• #60 Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4169219/

  While some studies have found that patients with MCI are often indistinguishable from elderly individuals who are cognitively intact, in terms of AD pathology, patients with a-MCI generally exhibit an intermediate degree of the histopathological hallmarks of AD. […] Patients with MCI are at an increased risk for developing AD relative to the general population. […] Although some data suggest that the rate of reversion to normal cognition may be as high as 25 to 30%, it is important to note that reversion to normal cognition at the time of short-term follow-up does not eliminate the possibility of later progression to dementia. […] Regardless of the classification system used, there are a number of important issues to take into account when considering a diagnosis of MCI. […] Once it has been determined that the patient meets the core clinical criteria for MCI, it is important to consider the likely primary etiology driving the MCI.

• #61 Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4169219/

  The criteria for mild NCD include: a) Evidence of modest cognitive decline from a previous level of performance in one or more cognitive domains (self/informant/clinician report or evident on neuropsychological tests), b) the cognitive deficits do not interfere with capacity for independence in everyday activities, c) the cognitive deficits do not occur exclusively in the context of a delirium, and d) the cognitive deficits are not better explained by another mental disorder. […] Although a great deal of work has been done to characterize the clinical profile of MCI, much less is known about the neuropathological profile of MCI. […] The longitudinal course of MCI is most clear for patients with a-MCI (or MCI due to AD), as these patients constitute a high risk group for AD, with nearly 10% to 15% of a-MCI patients progressing to a diagnosis of probable AD each year, relative to only 1% to 2% of the general elderly population.

• #62 Mild Cognitive Impairment (MCI): What You Need To Know

  https://www.healthline.com/health/mild-cognitive-impairment

  A study published in the British Journal of Psychiatry suggests that 60 to 65 percent of people with MCI will go on to develop clinical dementia. […] The chief complication associated with MCI, according to the National Institute on Aging, is developing Alzheimers disease or a related form of progressive dementia.

• #63 Reversion or compensation of mild cognitive impairment to normal cognition: strategies to prevent the development of Alzheimer’s disease continuum

  https://www.explorationpub.com/Journals/ent/Article/100490

  Imaging techniques such as NMR (nuclear magnetic resonance) or PET (positron emission tomography) scans can provide insights into brain changes that may correlate with the onset of MCI. […] MCI could follow the continuum to dementia or could reverse to normal condition […] Progression from MCI to dementia can occur in about 15% of cases within two years, and this progression may increase to one-third of MCI patients after five years. The conversion rate from MCI to AD varies widely, with reports ranging from 15% to 45%. Consequently, not all MCI patients progress to dementia; a proportion may even revert to normal cognitive function. […] Several studies have reported that MCI can revert to normal cognitive function, though the rate of reversion varies widely among different reports, ranging from 15% to 45%.

• #64 Mild Cognitive Impairment: Diagnosis, Longitudinal Course, and Emerging Treatments

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4169219/

  While some studies have found that patients with MCI are often indistinguishable from elderly individuals who are cognitively intact, in terms of AD pathology, patients with a-MCI generally exhibit an intermediate degree of the histopathological hallmarks of AD. […] Patients with MCI are at an increased risk for developing AD relative to the general population. […] Although some data suggest that the rate of reversion to normal cognition may be as high as 25 to 30%, it is important to note that reversion to normal cognition at the time of short-term follow-up does not eliminate the possibility of later progression to dementia. […] Regardless of the classification system used, there are a number of important issues to take into account when considering a diagnosis of MCI. […] Once it has been determined that the patient meets the core clinical criteria for MCI, it is important to consider the likely primary etiology driving the MCI.

• #65 Reversion or compensation of mild cognitive impairment to normal cognition: strategies to prevent the development of Alzheimer’s disease continuum

  https://www.explorationpub.com/Journals/ent/Article/100490

  Imaging techniques such as NMR (nuclear magnetic resonance) or PET (positron emission tomography) scans can provide insights into brain changes that may correlate with the onset of MCI. […] MCI could follow the continuum to dementia or could reverse to normal condition […] Progression from MCI to dementia can occur in about 15% of cases within two years, and this progression may increase to one-third of MCI patients after five years. The conversion rate from MCI to AD varies widely, with reports ranging from 15% to 45%. Consequently, not all MCI patients progress to dementia; a proportion may even revert to normal cognitive function. […] Several studies have reported that MCI can revert to normal cognitive function, though the rate of reversion varies widely among different reports, ranging from 15% to 45%.

• #66 Mild Cognitive Impairment: Background, Etiology, Pathophysiology

  https://emedicine.medscape.com/article/1136393-overview

  Subtypes of MCI progress to Alzheimer disease (AD) at different rates. A study by Rountree et al showed that the conversion rate to AD was 56% for amnestic MCI, 50% for amnestic-subthreshold MCI, and 52% for nonamnestic MCI. For all MCI subtypes, the 4-year conversion rate to dementia was 56% (14% annually), and that to Alzheimer disease was 46% (11% annually). In comparison, healthy elderly individuals develop AD at a rate of 1-2% per year. […] Ultimately, long-term follow-up and eventual autopsy are necessary to distinguish between patients experiencing MCI due to preclinical AD and patients experiencing MCI due to less frequently occurring conditions. However, there are some factors that can be helpful in predicting the likelihood of progression. […] The severity of memory impairment is predictive of progression to AD: patients with more severe memory impairment are more likely to progress. There are certain neuroradiologic features that predict progression of MCI. These include MRI findings of atrophy and volume loss in the medial temporal lobe as well as a hypometabolic pattern on FDG-PET scan. In addition, APOE4 genotype carriers are at higher risk of progression, but APoE4 testing is not recommended for routine use. A new modality that might prove useful in predicting and monitoring progression of MCI is a new PET tracer focusing on the role of tau. Early data suggests that spread of tau laterally, outside the medial temporal lobe, may predict a poor prognosis and a more rapid progression.

• #67 Mild Cognitive Impairment: Background, Etiology, Pathophysiology

  https://emedicine.medscape.com/article/1136393-overview

  Subtypes of MCI progress to Alzheimer disease (AD) at different rates. A study by Rountree et al showed that the conversion rate to AD was 56% for amnestic MCI, 50% for amnestic-subthreshold MCI, and 52% for nonamnestic MCI. For all MCI subtypes, the 4-year conversion rate to dementia was 56% (14% annually), and that to Alzheimer disease was 46% (11% annually). In comparison, healthy elderly individuals develop AD at a rate of 1-2% per year. […] Ultimately, long-term follow-up and eventual autopsy are necessary to distinguish between patients experiencing MCI due to preclinical AD and patients experiencing MCI due to less frequently occurring conditions. However, there are some factors that can be helpful in predicting the likelihood of progression. […] The severity of memory impairment is predictive of progression to AD: patients with more severe memory impairment are more likely to progress. There are certain neuroradiologic features that predict progression of MCI. These include MRI findings of atrophy and volume loss in the medial temporal lobe as well as a hypometabolic pattern on FDG-PET scan. In addition, APOE4 genotype carriers are at higher risk of progression, but APoE4 testing is not recommended for routine use. A new modality that might prove useful in predicting and monitoring progression of MCI is a new PET tracer focusing on the role of tau. Early data suggests that spread of tau laterally, outside the medial temporal lobe, may predict a poor prognosis and a more rapid progression.

• #68 Mild Cognitive Impairment: Background, Etiology, Pathophysiology

  https://emedicine.medscape.com/article/1136393-overview

  Subtypes of MCI progress to Alzheimer disease (AD) at different rates. A study by Rountree et al showed that the conversion rate to AD was 56% for amnestic MCI, 50% for amnestic-subthreshold MCI, and 52% for nonamnestic MCI. For all MCI subtypes, the 4-year conversion rate to dementia was 56% (14% annually), and that to Alzheimer disease was 46% (11% annually). In comparison, healthy elderly individuals develop AD at a rate of 1-2% per year. […] Ultimately, long-term follow-up and eventual autopsy are necessary to distinguish between patients experiencing MCI due to preclinical AD and patients experiencing MCI due to less frequently occurring conditions. However, there are some factors that can be helpful in predicting the likelihood of progression. […] The severity of memory impairment is predictive of progression to AD: patients with more severe memory impairment are more likely to progress. There are certain neuroradiologic features that predict progression of MCI. These include MRI findings of atrophy and volume loss in the medial temporal lobe as well as a hypometabolic pattern on FDG-PET scan. In addition, APOE4 genotype carriers are at higher risk of progression, but APoE4 testing is not recommended for routine use. A new modality that might prove useful in predicting and monitoring progression of MCI is a new PET tracer focusing on the role of tau. Early data suggests that spread of tau laterally, outside the medial temporal lobe, may predict a poor prognosis and a more rapid progression.

• #69 Mild Cognitive Impairment: Background, Etiology, Pathophysiology

  https://emedicine.medscape.com/article/1136393-overview

  Subtypes of MCI progress to Alzheimer disease (AD) at different rates. A study by Rountree et al showed that the conversion rate to AD was 56% for amnestic MCI, 50% for amnestic-subthreshold MCI, and 52% for nonamnestic MCI. For all MCI subtypes, the 4-year conversion rate to dementia was 56% (14% annually), and that to Alzheimer disease was 46% (11% annually). In comparison, healthy elderly individuals develop AD at a rate of 1-2% per year. […] Ultimately, long-term follow-up and eventual autopsy are necessary to distinguish between patients experiencing MCI due to preclinical AD and patients experiencing MCI due to less frequently occurring conditions. However, there are some factors that can be helpful in predicting the likelihood of progression. […] The severity of memory impairment is predictive of progression to AD: patients with more severe memory impairment are more likely to progress. There are certain neuroradiologic features that predict progression of MCI. These include MRI findings of atrophy and volume loss in the medial temporal lobe as well as a hypometabolic pattern on FDG-PET scan. In addition, APOE4 genotype carriers are at higher risk of progression, but APoE4 testing is not recommended for routine use. A new modality that might prove useful in predicting and monitoring progression of MCI is a new PET tracer focusing on the role of tau. Early data suggests that spread of tau laterally, outside the medial temporal lobe, may predict a poor prognosis and a more rapid progression.

• #70 Mild Cognitive Impairment: Background, Etiology, Pathophysiology

  https://emedicine.medscape.com/article/1136393-overview

  Subtypes of MCI progress to Alzheimer disease (AD) at different rates. A study by Rountree et al showed that the conversion rate to AD was 56% for amnestic MCI, 50% for amnestic-subthreshold MCI, and 52% for nonamnestic MCI. For all MCI subtypes, the 4-year conversion rate to dementia was 56% (14% annually), and that to Alzheimer disease was 46% (11% annually). In comparison, healthy elderly individuals develop AD at a rate of 1-2% per year. […] Ultimately, long-term follow-up and eventual autopsy are necessary to distinguish between patients experiencing MCI due to preclinical AD and patients experiencing MCI due to less frequently occurring conditions. However, there are some factors that can be helpful in predicting the likelihood of progression. […] The severity of memory impairment is predictive of progression to AD: patients with more severe memory impairment are more likely to progress. There are certain neuroradiologic features that predict progression of MCI. These include MRI findings of atrophy and volume loss in the medial temporal lobe as well as a hypometabolic pattern on FDG-PET scan. In addition, APOE4 genotype carriers are at higher risk of progression, but APoE4 testing is not recommended for routine use. A new modality that might prove useful in predicting and monitoring progression of MCI is a new PET tracer focusing on the role of tau. Early data suggests that spread of tau laterally, outside the medial temporal lobe, may predict a poor prognosis and a more rapid progression.

• #71 Mild Cognitive Impairment: The Benefits of Early Diagnosis | myALZteam

  https://www.myalzteam.com/resources/mild-cognitive-impairment-the-benefits-of-early-diagnosis

  Early diagnosis of mild cognitive impairment (MCI) is important, because some cases can progress to Alzheimers disease. […] Early diagnosis is done through a combination of cognitive testing, imaging, and laboratory tests. […] It is important to diagnose MCI as early as possible because some cases of MCI may progress to Alzheimers disease. […] The diagnosis of mild cognitive impairment usually starts when family or friends begin to notice that their loved one is becoming more forgetful, getting lost, or experiencing other symptoms of memory loss. […] Health care providers can use a variety of tests to help determine if someone has MCI. […] If your primary care doctor suspects MCI, they will usually recommend you see a specialist, such as a neuropsychologist. […] You may undergo imaging tests and blood or spinal fluid tests if your doctor suspects MCI.

• #72 Mild Cognitive Impairment: The Benefits of Early Diagnosis | myALZteam

  https://www.myalzteam.com/resources/mild-cognitive-impairment-the-benefits-of-early-diagnosis

  Research into the underlying biological causes of MCI will help improve the ability to diagnose it. […] Early diagnosis of mild cognitive impairment is very important, since some cases of MCI may progress to Alzheimers. […] Early diagnosis and intervention is important for several reasons. […] The primary benefit of early MCI diagnosis is that it helps identify individuals who are most at risk for dementia. […] Although diagnosing MCI isnt always easy, it is important to diagnose as soon as possible to identify any risk for Alzheimers and other forms of dementia.

• #73 Mild Cognitive Impairment: The Benefits of Early Diagnosis | myALZteam

  https://www.myalzteam.com/resources/mild-cognitive-impairment-the-benefits-of-early-diagnosis

  Research into the underlying biological causes of MCI will help improve the ability to diagnose it. […] Early diagnosis of mild cognitive impairment is very important, since some cases of MCI may progress to Alzheimers. […] Early diagnosis and intervention is important for several reasons. […] The primary benefit of early MCI diagnosis is that it helps identify individuals who are most at risk for dementia. […] Although diagnosing MCI isnt always easy, it is important to diagnose as soon as possible to identify any risk for Alzheimers and other forms of dementia.

• #74 Mild Cognitive Impairment (MCI): Symptoms, Causes, Help

  https://www.helpguide.org/aging/dementia/mild-cognitive-impairment-mci

  Early detection of MCI is crucial. An early diagnosis time gives you time to make lifestyle changes that may slow its progression or reverse it when possible. […] Various conditions can lead to or worsen mild cognitive impairment. Understanding the specific cause of your MCI can help you assess the most effective ways to manage the problem. […] When it comes to your odds of developing MCI, certain risk factors are simply out of your control. […] However, there are plenty of other risk factors that you can control or have treated. […] If you or a loved one already has MCI, youll want to identify which factors increase your risk of MCI progressing to Alzheimers or dementia. […] Depending on the cause of MCI, you might need to work with a doctor to address the underlying issue. […] However, there are also simple lifestyle changes you can adopt that may help to lower your risk factors, slow the rate of cognitive decline, or even reverse mild cognitive impairment.

• #75 What Is Mild Cognitive Impairment?

  https://www.alzheimers.gov/alzheimers-dementias/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is a condition in which people have more memory or thinking problems than other people their age. […] If you have this condition, its important to see a doctor or specialist regularly to help monitor changes in memory and thinking over time. […] If you or a loved one is experiencing symptoms of MCI, discuss these with your doctor. Your doctor can perform medical tests and assessments to help determine whether the source of memory problems is something treatable or may be MCI. […] People with MCI may worry that their memory problems will progress to Alzheimers disease or a related dementia. Because MCI may be an early sign of a more serious memory problem, its important to see your doctor every six to 12 months to track any changes in your memory and thinking skills over time. […] If symptoms do progress to dementia, getting a diagnosis early can help you and your family prepare for the future.

• #76

  https://link.springer.com/article/10.14283/jpad.2020.19

  Moreover, the inability to robustly identify patients at prodromal stages remains a substantial limitation for developing AD therapies and may, at least in part, contribute to the series of drug failures. […] Accordingly, early MCI detection may optimize identification of patients eligible for future clinical trials and maximize the likelihood of successfully developing novel AD therapies. […] An early identification of MCI also increases the possibility of a timely diagnosis of the medical condition that may underlie a cognitive impairment (i.e., secondary cause of MCI), which are all potentially treatable or even reversible. […] In the absence of a disease-modifying therapy in the immediate future, early detection also can identify potential candidates for research and clinical trials for therapies in development that target individuals in the earlier stages of their cognitive decline and disease.

• #77 Missed diagnosis: The hidden crisis of mild cognitive impairment in America

  https://dornsife.usc.edu/news/stories/hidden-crisis-of-mild-cognitive-impairment/

  Two new USC Dornsife studies suggest that of the 8 million Americans who have MCI, more than 90% dont know it an especially worrisome finding since early diagnosis is key to delaying onset of dementia and Alzheimers disease. […] The diagnosis revealed that Jean had mild cognitive impairment (MCI), a condition often linked to Alzheimers disease. […] Two studies from the USC Dornsife College of Letters, Arts and Sciences reveal that MCI is alarmingly under-diagnosed, with approximately 7.4 million unknowingly living with the condition. […] In one study, the researchers analyzed data from 40 million Medicare beneficiaries age 65 and older and compared the proportion diagnosed with the rate expected in this age group. They found that fewer than 8% of expected cases were actually diagnosed.

• #78 Missed diagnosis: The hidden crisis of mild cognitive impairment in America

  https://dornsife.usc.edu/news/stories/hidden-crisis-of-mild-cognitive-impairment/

  Two new USC Dornsife studies suggest that of the 8 million Americans who have MCI, more than 90% dont know it an especially worrisome finding since early diagnosis is key to delaying onset of dementia and Alzheimers disease. […] The diagnosis revealed that Jean had mild cognitive impairment (MCI), a condition often linked to Alzheimers disease. […] Two studies from the USC Dornsife College of Letters, Arts and Sciences reveal that MCI is alarmingly under-diagnosed, with approximately 7.4 million unknowingly living with the condition. […] In one study, the researchers analyzed data from 40 million Medicare beneficiaries age 65 and older and compared the proportion diagnosed with the rate expected in this age group. They found that fewer than 8% of expected cases were actually diagnosed.

• #79 Missed diagnosis: The hidden crisis of mild cognitive impairment in America

  https://dornsife.usc.edu/news/stories/hidden-crisis-of-mild-cognitive-impairment/

  Two new USC Dornsife studies suggest that of the 8 million Americans who have MCI, more than 90% dont know it an especially worrisome finding since early diagnosis is key to delaying onset of dementia and Alzheimers disease. […] The diagnosis revealed that Jean had mild cognitive impairment (MCI), a condition often linked to Alzheimers disease. […] Two studies from the USC Dornsife College of Letters, Arts and Sciences reveal that MCI is alarmingly under-diagnosed, with approximately 7.4 million unknowingly living with the condition. […] In one study, the researchers analyzed data from 40 million Medicare beneficiaries age 65 and older and compared the proportion diagnosed with the rate expected in this age group. They found that fewer than 8% of expected cases were actually diagnosed.

• #80 Missed diagnosis: The hidden crisis of mild cognitive impairment in America

  https://dornsife.usc.edu/news/stories/hidden-crisis-of-mild-cognitive-impairment/

  The second study looked at 200,000 individual primary care clinicians and found that 99% of them underdiagnosed MCI. […] MCI by definition doesnt cause disability whereas dementia is a disabling condition marked by more serious cognitive difficulties. […] MCI can come in various forms: Forgetfulness is the most familiar form, Borson says. […] MCI might be underdiagnosed for various reasons. […] Detection of cognitive impairment is not difficult, but it does not occur without planning. […] But early treatment is vital, says Mattke, because the brain is limited in its ability to recover brain cells, once lost, do not grow back, and any damage can no longer be repaired. […] For MCI caused by Alzheimers disease, the earlier you treat, the better your outcomes, he says.

• #81 Mild cognitive impairment and dementia: detection and diagnosis | Medicine Today

  https://medicinetoday.com.au/mt/2024/may/feature-article/mild-cognitive-impairment-and-dementia-detection-and-diagnosis

  If uncertain, mild cognitive impairment may be considered as a diagnosis and the patient monitored over time. […] Only about 8% of patients in primary care older than 65 years of age with MCI have a formal diagnosis of MCI. […] Confirming the diagnosis of MCI allows the primary care team, together with the patient and their family, to implement brain health strategies and to monitor cognition and function regularly. […] The diagnostic criteria for MCI and dementia are presented in Box 1. […] GPs and practice nurses are critical in recognising possible cognitive and functional changes and initiating assessment. GPs are encouraged to develop the confidence to diagnose dementia, particularly in regions where there is limited access to specialists. […] After reviewing the findings of the assessments, consider differential diagnoses, such as delirium and depression, and reversible causes of cognitive impairment.

• #82 EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CARE • The Journal of Prevention of Alzheimer’s Disease

  https://www.jpreventionalzheimer.com/4040-early-detection-of-mild-cognitive-impairment-mci-in-primary-care.html

  Mild cognitive impairment (MCI) is significantly misdiagnosed in the primary care setting due to multi-dimensional frictions and barriers associated with evaluating individuals cognitive performance. […] This report summarizes a conceptual framework and provides guidance to clinical researchers and test developers and suppliers to inform ongoing refinement of cognitive evaluation. […] The rising global incidence of AD demands innovation that will help alleviate the burden to healthcare systems when coupled with the potentially near-term approval of disease-modifying therapies. […] Mild Cognitive Impairment (MCI) is a syndrome defined by clinical, cognitive, and functional criteria and is characterized by an objective cognitive decline in one or more cognitive domains without any significant impairment in daily-life activities.

• #83

  https://www.healthxchange.sg/seniors/ageing-concerns/mild-cognitive-impairment-diagnosis-treatment

  Mild Cognitive Impairment (MCI): Diagnosis and Treatment […] The Department of Neurology at Singapore General Hospital shares the tests used for diagnosis and other treatment methods. […] It is not easy to diagnose MCI. This is because not everyone will clearly exhibit all the signs and symptoms of the disorder, which appear gradually. […] In fact, these signs and symptoms may remain stable or improve over time. Or the condition might worsen to Alzheimers disease or another type of dementia, Dr Kandiah says. […] There is also no specific cognitive test that you can do to confirm the diagnosis. To better assess you, your doctor might recommend that you undergo a series of tests, including psychological assessment, blood tests, brain imaging, and a neurological exam. […] But the biggest obstacle to a proper diagnosis of MCI is that memory loss, the most significant symptom of the disorder, tends to be viewed as a normal part of ageing and a sufferer may not consult a doctor.

• #84 What Is Mild Cognitive Impairment, and How is it Diagnosed? – The New York Times

  https://www.nytimes.com/2024/02/06/well/mind/mild-cognitive-impairment-diagnosis.html

  Mike Davis’s mother died from Alzheimer’s disease in 2008. So when Mr. Davis started noticing that he was having an increasing number of “senior moments” at age 76 — such as forgetting to water his plants, something he was normally regimented about — he decided to have his cognition tested. After administering an evaluation, Mr. Davis’s doctor told him he had mild cognitive impairment. Millions of Americans are thought to have M.C.I., though exact numbers are hard to pin down because experts say the condition is underdiagnosed. There are likely several reasons for that: M.C.I. can be tricky to identify during a primary care visit, when physicians typically only have 15 minutes or so with a patient. People may also be scared to disclose their concerns to a doctor, or might not even realize that they have a problem. Here’s what to know about what M.C.I. is and how it’s diagnosed.

• #85 EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CARE • The Journal of Prevention of Alzheimer’s Disease

  https://www.jpreventionalzheimer.com/4040-early-detection-of-mild-cognitive-impairment-mci-in-primary-care.html

  In some circumstances, testing tools are poorly designed and/or unintuitive for users. […] This increases system burden due to cost, which decreases the frequency of cognitive performance assessment. […] The limited length of time of the average PCP visit requires tests to be conducted in 10 minutes or less. […] Testing all domains of cognition in a short test is likely not feasible, so tools must strike a proper balance between time and depth of testing to maximize their utility. […] Early detection of MCI is also inherently challenging due to barriers associated with the disease itself. […] Symptoms related to the initial onset of MCI can vary significantly between individuals, depending on etiology, cognitive reserve, and variable demands of day-to-day living, among other factors.

• #86 EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CARE • The Journal of Prevention of Alzheimer’s Disease

  https://www.jpreventionalzheimer.com/4040-early-detection-of-mild-cognitive-impairment-mci-in-primary-care.html

  Training programs for Primary Care providers incorporate limited exposure to these skills. […] As a result, many PCPs are left feeling poorly equipped, inexperienced, or uncomfortable about monitoring cognitive performance. […] In addition, if cognitive impairment is detected, PCPs may face uncertainty about what next steps to pursue. […] Finally, PCPs likely face low motivation to evaluate an individuals cognitive status, given uncertainty around whether or not identifying MCI provides a clear benefit to the individual. […] Barriers associated with healthcare systems also significantly limit widespread early detection of MCI, as exploring all cognitive domains and quantifying overall cognitive performance is currently a time-consuming process. […] Poor integration of cognitive assessments with EMR systems creates a significant administrative burden, as substantial clerical work is needed to document the output of a cognitive performance assessment.

• #87 Early Cognitive Decline Is Underdiagnosed | TIME

  https://time.com/6328148/mci-cognitive-decline-under-diagnosed/

  Getting an MCI diagnosis currently requires a lot of unlikely pieces to fall into place, explains Mattke. […] In some people, it could manifest as unusual memory lapses, in others issues with orientation, and in others still as struggles with information processing or decision making. […] Neurological decline can be a major source of shame for older adults, who may go out of their way to compensate for symptoms in order to avoid detection by family members and clinical evaluation. […] Because MCI is, by definition, mild, its also unlikely to be noticed by someone who doesnt know the patient well or doesnt spend much time with them, including their primary care physician. […] Good tests for MCI do exist, and if a patient arrives with concerns about mental impairment, a physician might administer the simplest one, which takes about 15 minutes to conduct and score.

• #88 EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CARE • The Journal of Prevention of Alzheimer’s Disease

  https://www.jpreventionalzheimer.com/4040-early-detection-of-mild-cognitive-impairment-mci-in-primary-care.html

  In some circumstances, testing tools are poorly designed and/or unintuitive for users. […] This increases system burden due to cost, which decreases the frequency of cognitive performance assessment. […] The limited length of time of the average PCP visit requires tests to be conducted in 10 minutes or less. […] Testing all domains of cognition in a short test is likely not feasible, so tools must strike a proper balance between time and depth of testing to maximize their utility. […] Early detection of MCI is also inherently challenging due to barriers associated with the disease itself. […] Symptoms related to the initial onset of MCI can vary significantly between individuals, depending on etiology, cognitive reserve, and variable demands of day-to-day living, among other factors.

• #89 Mild Cognitive Impairment (MCI): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17990-mild-cognitive-impairment

  Because MCI may be an early sign of more serious neurological conditions, its important to see a healthcare provider or specialist every six to 12 months. This may depend on your treatment plan. Your provider can help track changes in memory and thinking skills over time and suggest changes that are relevant to your health. Keeping a personal record of any changes can also be helpful.

• #90 What Is Mild Cognitive Impairment?

  https://www.alzheimers.gov/alzheimers-dementias/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is a condition in which people have more memory or thinking problems than other people their age. […] If you have this condition, its important to see a doctor or specialist regularly to help monitor changes in memory and thinking over time. […] If you or a loved one is experiencing symptoms of MCI, discuss these with your doctor. Your doctor can perform medical tests and assessments to help determine whether the source of memory problems is something treatable or may be MCI. […] People with MCI may worry that their memory problems will progress to Alzheimers disease or a related dementia. Because MCI may be an early sign of a more serious memory problem, its important to see your doctor every six to 12 months to track any changes in your memory and thinking skills over time. […] If symptoms do progress to dementia, getting a diagnosis early can help you and your family prepare for the future.

• #91 Mild Cognitive Impairment (MCI): Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17990-mild-cognitive-impairment

  Because MCI may be an early sign of more serious neurological conditions, its important to see a healthcare provider or specialist every six to 12 months. This may depend on your treatment plan. Your provider can help track changes in memory and thinking skills over time and suggest changes that are relevant to your health. Keeping a personal record of any changes can also be helpful.

• #92 Mild Cognitive Impairment (MCI) | Symptoms & Treatments | alz.org

  https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment

  Experts believe that many cases but not all result from brain changes occurring in the very early stages of Alzheimer’s or other neurodegenerative diseases that cause dementia. […] More research is needed on the biological changes associated with normal aging, MCI and Alzheimers and other dementias to better understand the causes of and risk factors for MCI and the prognosis for those with the condition. […] Individuals who have been diagnosed with MCI should be reevaluated every six months to determine if symptoms have progressed.

• #93 What is mild cognitive impairment? – Dementia UK

  https://www.dementiauk.org/information-and-support/health-advice/what-is-mild-cognitive-impairment/

  If these checks identify an underlying cause of your symptoms, these can often be managed with medication, lifestyle changes or talking therapies. […] However, if the GP cannot find any pre-existing conditions and feels that the symptoms you are experiencing are not simply normal age-related changes, they may refer you to a memory clinic for further assessments. […] This may result in a diagnosis of MCI or – if the symptoms and changes are more severe – a diagnosis of dementia. […] Following a diagnosis of MCI, your GP should invite you for a review after 12 months – if you are not contacted, or if you notice a worsening in your symptoms before then, you can book an appointment yourself.

• #94 What a Mild Cognitive Impairment Diagnosis Really Means

  https://neurotrack.com/resources/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is a slight, but noticeable decline in memory and thinking. […] The cognitive decline is significant enough to be noticed by the person and those around them but, unlike Alzheimer’s or dementia, MCI does not interfere with a person’s ability to take care of themselves and participate in normal daily activities. […] MCI is a clinical diagnosis and there is no one medical test for diagnosing the condition. […] The process for diagnosing MCI typically includes a thorough medical exam and patient history including a review of all medications the patient is taking, a short in-office mental status test assessing memory, attention, and short-term recall, input from the patient and family members about recent cognitive decline, and a more in-depth neuropsychological may be ordered to determine the degree of memory impairment. […] After a diagnosis of MCI, a person should be evaluated every six to twelve months for signs of further decline.

• #95 What a Mild Cognitive Impairment Diagnosis Really Means

  https://neurotrack.com/resources/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is a slight, but noticeable decline in memory and thinking. […] The cognitive decline is significant enough to be noticed by the person and those around them but, unlike Alzheimer’s or dementia, MCI does not interfere with a person’s ability to take care of themselves and participate in normal daily activities. […] MCI is a clinical diagnosis and there is no one medical test for diagnosing the condition. […] The process for diagnosing MCI typically includes a thorough medical exam and patient history including a review of all medications the patient is taking, a short in-office mental status test assessing memory, attention, and short-term recall, input from the patient and family members about recent cognitive decline, and a more in-depth neuropsychological may be ordered to determine the degree of memory impairment. […] After a diagnosis of MCI, a person should be evaluated every six to twelve months for signs of further decline.

• #96 What a Mild Cognitive Impairment Diagnosis Really Means

  https://neurotrack.com/resources/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is a slight, but noticeable decline in memory and thinking. […] The cognitive decline is significant enough to be noticed by the person and those around them but, unlike Alzheimer’s or dementia, MCI does not interfere with a person’s ability to take care of themselves and participate in normal daily activities. […] MCI is a clinical diagnosis and there is no one medical test for diagnosing the condition. […] The process for diagnosing MCI typically includes a thorough medical exam and patient history including a review of all medications the patient is taking, a short in-office mental status test assessing memory, attention, and short-term recall, input from the patient and family members about recent cognitive decline, and a more in-depth neuropsychological may be ordered to determine the degree of memory impairment. […] After a diagnosis of MCI, a person should be evaluated every six to twelve months for signs of further decline.

• #97 What a Mild Cognitive Impairment Diagnosis Really Means

  https://neurotrack.com/resources/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is a slight, but noticeable decline in memory and thinking. […] The cognitive decline is significant enough to be noticed by the person and those around them but, unlike Alzheimer’s or dementia, MCI does not interfere with a person’s ability to take care of themselves and participate in normal daily activities. […] MCI is a clinical diagnosis and there is no one medical test for diagnosing the condition. […] The process for diagnosing MCI typically includes a thorough medical exam and patient history including a review of all medications the patient is taking, a short in-office mental status test assessing memory, attention, and short-term recall, input from the patient and family members about recent cognitive decline, and a more in-depth neuropsychological may be ordered to determine the degree of memory impairment. […] After a diagnosis of MCI, a person should be evaluated every six to twelve months for signs of further decline.

• #98 What a Mild Cognitive Impairment Diagnosis Really Means

  https://neurotrack.com/resources/mild-cognitive-impairment

  Mild cognitive impairment (MCI) is a slight, but noticeable decline in memory and thinking. […] The cognitive decline is significant enough to be noticed by the person and those around them but, unlike Alzheimer’s or dementia, MCI does not interfere with a person’s ability to take care of themselves and participate in normal daily activities. […] MCI is a clinical diagnosis and there is no one medical test for diagnosing the condition. […] The process for diagnosing MCI typically includes a thorough medical exam and patient history including a review of all medications the patient is taking, a short in-office mental status test assessing memory, attention, and short-term recall, input from the patient and family members about recent cognitive decline, and a more in-depth neuropsychological may be ordered to determine the degree of memory impairment. […] After a diagnosis of MCI, a person should be evaluated every six to twelve months for signs of further decline.

• #99 What Is Mild Cognitive Impairment, and How is it Diagnosed? – The New York Times

  https://www.nytimes.com/2024/02/06/well/mind/mild-cognitive-impairment-diagnosis.html

  If a person is diagnosed with M.C.I., they may be referred for more extensive cognitive testing with a neuropsychologist, and they should receive other assessments, like brain scans and blood tests, to determine what the underlying cause of their issue might be. […] A diagnosis alone can’t explain what’s behind a person’s symptoms, said Dr. Carolyn Fredericks, an assistant professor of neurology at Yale School of Medicine. “And that, of course, is the most important piece and the one that has the most meaning for the patient in terms of, ‘How worried should we be, and what does this mean for the future?’”

• #100 Mild cognitive impairment and dementia: detection and diagnosis | Medicine Today

  https://medicinetoday.com.au/mt/2024/may/feature-article/mild-cognitive-impairment-and-dementia-detection-and-diagnosis

  GPs report that they find delivering a dementia diagnosis difficult and complex. […] If a GP feels confident that the patient meets the criteria for dementia, then they can deliver the diagnosis themselves. […] Timely diagnosis of MCI and dementia accompanied by ongoing management and support by the primary care team is beneficial for the patient and their family while mitigating some of the negative consequences of being given the diagnosis.

Zobacz więcej